CDKN3 and acute myeloid leukemia: (2015), showing that in acute myeloid leukemia (AML) in around 30% of examined cases hypermethylation of TWIST2 occurred leading to reduced expression of both TWIST2 and the cyclin‐dependent kinase inhibitor p21.